Visualization of a Bruton’s Tyrosine Kinase Inhibitor Using Fluorescence and Raman Microscopy
Andrew S. Merchant, William J. Tipping, Duncan Graham, Karen Faulds · 2026
Read Visualization of a Bruton’s Tyrosine Kinase Inhibitor Using Fluorescence and Raman Microscopy by Andrew S. Merchant, William J. Tipping, Duncan Graham, Karen Faulds (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13191727.txt.
Description
Andrew Merchant, William Tipping, Duncan Graham, and Karen Faulds published this imaging study in 2026. It asks how researchers can watch a cancer drug move inside cells without changing the drug itself. The drug is ibrutinib, which blocks an enzyme called Bruton's tyrosine kinase. The team made two tagged copies of it: one that glows, and one that can be seen with Raman light scattering.
The glowing copy stuck to cells even where the enzyme was absent, which makes its images hard to trust. The Raman copy, by contrast, stayed in cells in line with how much of the enzyme they held. The team also used Raman spectra to show that blocking the enzyme raised the amount of fat in the cells. Their results favor Raman imaging for tracking drugs of this kind.
Catalog record
| CREATOR | Andrew S. Merchant, William J. Tipping, Duncan Graham, Karen Faulds |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |